In this episode of ASTCT Talks, Dr. Shernan Holtan welcomes Andrew Lin, Manager of Clinical Pharmacy Services of Adult BMT and CTS at Memorial Sloan Kettering Cancer Center, to discuss the evolving role of tacrolimus levels in GVHD prophylaxis within the post-transplant cyclophosphamide (PTCy) era. They explore findings from a recent retrospective study examining whether higher tacrolimus levels offer added protection against GVHD, what this means for toxicity and patient outcomes and how these insights are shaping dosing strategies. The conversation also looks ahead to future research areas, including MMF optimization and the potential for simplified, patient-centered prophylaxis regimens.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
Lucy Liu
18 Dec 2025
Fresh Air
#2428 - Michael P. Masters
18 Dec 2025
The Joe Rogan Experience
Entré al ejército para ser narco | Alberto
18 Dec 2025
Penitencia
¿En búsqueda de la felicidad?
18 Dec 2025
Psicologia Al Desnudo | @psi.mammoliti
CHARLIE CHARLES | Finalmente parla Charlie! 🎧 | Passa dal BSMT _ S05E25
18 Dec 2025
Passa dal BSMT